Galle P et al. Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein following sorafenib: Outcomes by liver disease aetiology front wo randomised, placebo-controlled phase 3 studies (REACH-2 and REACH). (Abstract GS-09)
Nederlands onderzoek naar 'dirty money' wint Ig Nobelprijs
sep 2019 | Bacteriële infecties, Overig